Skip to main content
IRWD logo

IRWD · Ironwood Pharmaceuticals Inc · Analyst Estimates

Track IRWD — free
$4.67 -0.12 (-2.41%) Play latest call Q3 2026 earnings call transcript
Market Cap
$767.33M
Shares
165.55M
Volume · Nov 19 948.72K Avg daily vol (3M) 2.1M

Analyst Estimates

Compare analyst forecasts for Ironwood Pharmaceuticals Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-15 20:05 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.28
1.30
1.32
2
1.21
1.21
1.21
1.21
0
0
1
1
Revenue
USD
Publication date not stated
489.10M
493.63M
497.80M
3
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.36
1.57
1.82
3
1.50
1.50
1.50
1.50
0
0
1
1
Revenue
USD
Publication date not stated
470.30M
504.23M
530.60M
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.37
0.39
0.41
2
0.34
0.34
0.39
0.39
0
0
1
1
Revenue
USD
Publication date not stated
122.00M
136.20M
145.20M
4
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.26
0.31
0.35
2
0.30
0.30
0.30
0.30
0
0
1
1
Revenue
USD
Publication date not stated
108.90M
108.90M
108.90M
1
— — — — — — — —
Key facts CIK 1446847 CUSIP 46333X108 13F (30d) 243 filings 221 filers Visit website Investor relations